Concurrent cisplatin-based radiotherapy and chemotherapy improves survival of cervical cancer

被引：0
|
作者：
Dunst, J [1 ]
Sauer, R
机构：
[1] Univ Halle Wittenberg, Klin Strahlentherapie, D-06097 Halle, Germany
[2] Univ Erlangen Nurnberg, Klin Strahlentherapie, D-8520 Erlangen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 1999年 / 175卷 / 06期
关键词：
D O I：
10.1007/BF02743575
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：257 / 258
页数：2
相关论文
共 50 条
  • [41] Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
    Hu, Ming-Hung
    Wang, Ling-Wei
    Lu, Hsueh-Ju
    Chu, Pen-Yuan
    Tai, Shyh-Kuan
    Lee, Tsung-Lun
    Chen, Ming-Huang
    Yang, Muh-Hwa
    Chang, Peter Mu-Hsin
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [42] Carboplatin-based vs. cisplatin-based therapy for cervical cancer survival: A systematic review
    Kumar, Chandni
    Faldo, Greg
    Aurelia, Clarissa Jasmine
    Tumiwa, Gabriella Hilary
    Mandaring, Putri Patricia
    Kurniawan, Andree
    ANNALS OF ONCOLOGY, 2023, 34 : S1440 - S1440
  • [43] Cisplatin monotherapy with concurrent radiotherapy versus combination of cisplatin and 5-fluorouracil chemotherapy with concurrent radiotherapy in patients with locoregionally advanced cervical carcinoma
    Nedovic, J.
    Protrka, Z.
    Ninkovic, S.
    Mitrovic, S.
    Vojinovic, R.
    Glisic, J.
    Markovic-Filipovic, B.
    Milosevic, B.
    Peulic, M.
    Cvetkovic, A.
    JOURNAL OF BUON, 2012, 17 (04): : 740 - 745
  • [44] Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy
    Galsky, Matt D.
    Krege, Susanne
    Lin, Chia-Chi
    Hahn, Noah M.
    Ecke, Thorsten
    Moshier, Erin L.
    Sonpavde, Guru
    Godbold, James H.
    Oh, William K.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    M B Polee
    W C J Hop
    T C Kok
    F A L M Eskens
    M E L van der Burg
    T A W Splinter
    P D Siersema
    H W Tilanus
    G Stoter
    A van der Gaast
    British Journal of Cancer, 2003, 89 : 2045 - 2050
  • [46] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    Polee, MB
    Hop, WCJ
    Kok, TC
    Eskens, FALM
    van der Burg, MEL
    Splinter, TAW
    Siersema, PD
    Tillanus, HW
    Stoter, G
    van der Gaast, A
    BRITISH JOURNAL OF CANCER, 2003, 89 (11) : 2045 - 2050
  • [47] Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis
    Li, Gang
    Niu, Hui-min
    Wu, Hong-tao
    Lei, Bao-yu
    Wang, Xiao-hua
    Guo, Xiao-bo
    Feng, Shu-lin
    CLINICAL AND INVESTIGATIVE MEDICINE, 2017, 40 (02): : E81 - E94
  • [48] Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy
    Apolo, Andrea B.
    Ostrovnaya, Irina
    Halabi, Susan
    Iasonos, Alexia
    Philips, George K.
    Rosenberg, Jonathan E.
    Riches, Jamie
    Small, Eric J.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (07): : 499 - 503
  • [49] Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer
    Yen, MS
    Juang, CM
    Lai, CR
    Chao, GC
    Ng, HT
    Yuan, CC
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2001, 72 (01) : 55 - 60
  • [50] ACCELERATED CISPLATIN-BASED CHEMOTHERAPY FOR ADVANCED BLADDER-CANCER
    BOSHOFF, C
    OLIVER, RTD
    GALLAGHER, CJ
    ONG, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1633 - 1636
12345